“It might start becoming the top circulating lineage,” Rajnaranayam said, predicting XEC will take the rest of October and ...

In fall and winter, COVID-19 transmission usually rises. LA County offers free boosters at county clinics and vaccination ...

Maryland healthcare professionals are concerned by the short supply of IV fluid caused by the fallout from Hurricane Helene ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

The CBOE Volatility index, Wall Street's fear gauge, closed up 3.4 points at 22.64, marking its biggest one-day points gain ...

Once thought of as a disease of age, new data about heart attacks is worrisome since it shows that it’s happening more often ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

--Pfizer's Chief Executive Albert Bourla plans to meet Starboard Value next week with at least one other director after the activist investor acquired a $1 billion stake in the healthcare company, the ...

Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.